Wednesday, 27 February 2013
Drug firm Roche pledges greater access to trials data.
The pharmaceutical company Roche has announced that it will make more of the data from its clinical trials available to researchers.
But the announcement has been dismissed as "pathetic" by campaigners arguing for greater transparency from the pharmaceutical industry - an issue I wrote about last month.
It's estimated that half of all clinical trials have never been published and positive trial results are twice as likely to be published as negative findings. The AllTrials campaign wants the pharmaceutical industry to publish all data, and is supported by the Wellcome Trust, the BMJ and NICE.
The doctor and columnist Ben Goldacre, who has spearheaded the campaign for data transparency said GSK had "led the field" by signing up to AllTrials and it was "bizarre to see that Roche expect to be praised today for continuing to withhold data." He predicted that the era of drug companies and researchers "routinely withholding important information about clinical trials is coming to an end."